Patents by Inventor Anthony E. Maida

Anthony E. Maida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTITUMOR PROTOCOL
    Publication number: 20150079027
    Abstract: Improved protocols that enhance the effect of immunotherapy against tumors are described. The protocol involves enhancing the immune response to an antitumor vaccine by maximizing the ability of T cells induced by the vaccine to extravasate into the tumor and also to modulate the effect of Tregs so that the effectiveness of the vaccine is not undermined. The former effect is achieved by radiation at the site of the tumor or lesions. This latter effect is achieved by an initial depletion of Tregs in combination with modulating their effect during the vaccine administration protocol.
    Type: Application
    Filed: March 26, 2013
    Publication date: March 19, 2015
    Applicant: DENDRITHERAPEUTICS, INC.
    Inventor: Anthony E. Maida, III
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20110064691
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 17, 2011
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond BEARDSLEY, Anthony E. Maida, III
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20080267913
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: May 23, 2008
    Publication date: October 30, 2008
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida
  • Method to enhance hematopoiesis
    Patent number: 7196060
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: March 27, 2007
    Assignee: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida, III
  • Method to elicit an antitumor response with human prostate-specific antigen
    Patent number: 5925362
    Abstract: Vaccines capable of eliciting an immune antitumor response for prostate tumors are disclosed. The active ingredient in such vaccines is selected from the group consisting of human PSA and expression system capable of generating in situ human PSA.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: July 20, 1999
    Assignee: Jenner Technologies
    Inventors: Lynn E. Spitler, Anthony E. Maida, III